The company was founded in 1968. It has more than 3600 employees. The gross assets have reached Ұ 1490 million. In 2004, the production value reached Ұ 1230 million, the sales income reached Ұ 1076 million, the profits reached Ұ 390 million, the tax paid to the government reached Ұ 160 million. For the series of eight years, our tax is over Ұ 100 million, and we become the biggest tax payment company in the city.

LUNAN PHARMACEUTICAL GROUP CORPORATION has six subsidiary companies.
- SHANDONG LUNAN BETTER PHARMACEUTICAL CO., LTD.
- LUNAN HOPE PHARMACEUTICAL CO., LTD.
- SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
- SHANDONG LUNAN NEW TIME MEDICAMENT CO., LTD.
- BEIJING PINGNUO SCIENCE AND TECHNOLOG CO., LTD.
- SHANDONG FEIXIAN MEDICAL PACKAGE CO., LTD.

LUNAN PHARMACEUTICAL GROUP CORPORATION collaborated with Shandong University on the founding of the natural drug research academe and the superficial fluid technology research institute. At present, the company has affiliates with the most advanced New Drug Research Center, the national largest Drug Analyzing Test Center, a National Chiral Intermediates Laboratory and a Postdoctoral scientific research workstation. There are over 10 doctors and 30 masters working in LUNAN PHARMACEUTICAL GROUP CORPORATION. The API of Mosapride Citrate and Milrinone won the national science and technology progress award.